Evidence map›Paper›PMID 39129958›Full record

ArticleGastro hep advances2024

Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era.

Priyanka Athavale, Robert J Wong, Derek D Satre, Alexander Monto, Ramsey Cheung, Jennifer Y Chen, Steven L Batki, Michael J Ostacher, Hannah R Snyder, Brigita D Widiarto and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Gastro hep advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05191446 (Impact of the Coronavirus 2019), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05191446 naactive not recruitingnot on this map

Impact of the Coronavirus 2019 (COVID-19) Pandemic on Patient Outcomes, Telehealth Care Delivery, and Treatment for Unhealthy Alcohol Use in Vulnerable Patients With Advanced Liver Disease Across Two Healthcare Systems

TypeinterventionalSponsorUniversity of California, San FranciscoRan2022 to 2026Enrolled180ConditionsLiver Diseases, Alcohol Use DisorderArmsStepped alcohol intervention (SAT) to reduce unhealthy alcohol use, Usual Care (UC)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Priyanka AthavaleDivision of Internal Medicine, University of California, San Francisco, San Francisco, California.
Robert J WongDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
Derek D SatreDepartment of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, California.
Alexander MontoDivision of Gastroenterology and Hepatology, Veterans Affairs San Francisco Health Care System, San Francisco, California.
Ramsey CheungDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
Jennifer Y ChenDivision of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, California.
Steven L BatkiDepartment of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, California.
Michael J OstacherDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.
Hannah R SnyderDepartment of Family and Community Medicine, University of California, San Francisco, California.
Brigita D WidiartoDivision of Gastroenterology and Hepatology, Zuckerberg San Francisco General, San Francisco, California.
Seo Yoon OhDivision of Gastroenterology and Hepatology, Veterans Affairs San Francisco Health Care System, San Francisco, California.
Meimei LiaoDivision of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Adele M L VivianiDivision of Gastroenterology and Hepatology, Zuckerberg San Francisco General, San Francisco, California.
Mandana KhaliliDivision of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, California.

Funding

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systemsR01AA029312 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KHALILI, MANDANA, SATRE, DEREK D · 2021 to 2025
$3.5M
Mentoring Multidisciplinary Patient-Oriented Research in Viral HepatitisK24AA022523 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KHALILI, MANDANA · 2013 to 2023
$1.9M
Mentoring alcohol use intervention research in HIV health care settingsK24AA025703 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre · 2018 to 2026
$1.8M
NIAAA NIH HHS K24 AA022523NIAAA NIH HHS K24 AA025703NIAAA NIH HHS R01 AA029312
6 · The paper itself

Abstract

Background and Aims: Telehealth has emerged as an important mode of cirrhosis care delivery, but its use and satisfaction among vulnerable populations (eg, racial/ethnic minorities, socioeconomically disadvantaged, substance use disorders) are unknown. We evaluated digital capacity, telehealth use, satisfaction and associated factors among patients receiving hepatology care via telehealth (telehepatology) across 2 Veterans Affairs and 1 safety-net Healthcare systems. Methods: English- and Spanish-speaking adults with cirrhosis (N = 256) completed surveys on telehealth use and satisfaction, quality of life, pandemic stress, alcohol use and depression. Logistic regression analyses assessed telehealth use and general linear models evaluated telehealth satisfaction. Results: The mean age was 64.5 years, 80.9% were male and 35.9% Latino; 44.5% had alcohol-associated cirrhosis; 20.8% had decompensated cirrhosis; 100% had digital (phone/computer) capacity; and 75.0% used telehepatology in the prior 6 months. On multivariable analysis, participants with alcohol-associated (vs not) cirrhosis were less likely and those with greater pandemic stress were more likely to use telehepatology (odds ratio = 0.46 and 1.41, respectively; Conclusion: Participants had high telehepatology capacity, yet demographics and alcohol-related problems influenced telehepatology use and satisfaction. Findings underscore the need for interventions to enhance patient experience with telehepatology for certain vulnerable groups including those with alcohol-associated cirrhosis in order to optimize care delivery.

Indexed as

Alcohol-Associated Liver DiseaseMetabolic dysfunction-associated steatotic liver diseaseMetALDNonalcoholic Fatty Liver DiseaseTelemedicineUnderserved

Identifiers

PMID39129958
PMCPMC11307565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.